Nicaraguans Seek Vaccines in Honduras, Moderna Safe for Kids, New US Travel Rules, More

Thousands of Nicaraguans go to Honduras border for vaccines

A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker and a medical syringe in this illustration taken  October 30, 2020. REUTERS/Dado Ruvic

TEGUCIGALPA, Oct 25 (Reuters) – Nearly 8,000 Nicaraguans received COVID-19 vaccines at two customs border crossings with neighboring Honduras in recent days, Honduran health authorities said on Monday, as supplies of the inoculations in Nicaragua have run low.

Promoting the vaccines for Nicaraguans, Honduran President Juan Orlando Hernandez wrote in a post on Twitter that “the solidarity and brotherhood of Hondurans crosses borders.” He added that up to 500 doses were being given out daily to Nicaraguans.

Honduran health authorities also pitched the cross-border assistance as a way to help beat back the risk of more infections at home.

“They don’t have access to vaccines in Nicaragua and that becomes a risk for us due to the significant movement of people along the border,” said Honduran regional health official Jose Maria Paguada.

Officials in Nicaragua did not immediately respond to a request for comment.

The border vaccines doled out in Honduras’ southwestern Choluteca department utilize donated inoculations made by Moderna and Pfizer, and will go through Nov. 6 for first doses, with second doses to follow, Honduran officials said.

To date, Honduras has confirmed more than 370,000 coronavirus infections and nearly 10,200 deaths as a result of the highly contagious respiratory disease caused by the virus.

Reporting by Gustavo Palencia; Additional reporting by Ismael Lopez; Writing by David Alire Garcia; Editing by Rosalba O’Brien

==========================================

COVID-19 vaccine safe, effective in kids 6-11

 

Moderna’s COVID-19 vaccine generated a strong immune response in children and was generally well tolerated, the company announced Monday.

In its study, Moderna determined that children aged 6 to 11 years old, who were vaccinated with two 50 microgram doses, had 1.5 times higher antibody levels than those observed among vaccinated young adults.

The dosage used for the children is half of the 100 micrograms used for the initial two adult shots, but the same amount authorized for the booster shot.

With the vaccine, these children showed a “robust neutralizing antibody response” and a “favorable safety profile” consistent with adolescent and adult response, the company noted.

Most adverse events were considered mild or moderate, with the most prevalent symptoms being fatigue, headache, fever and injection site pain.

What’s next: The company said it plans to submit data to the Food and Drug Administration (FDA) and other regulators, including in Europe, “in the near term.”

The announcement comes a day before an FDA advisory panel is scheduled to discuss data on Pfizer-BioNTech’s COVID-19 vaccine for 5- to 11-year-olds.

NEW US TRAVEL RULES

The Biden administration outlined on Monday very narrow exemptions that will permit unvaccinated international travelers to enter the United States.

Anyone who is under the age of 18 traveling from overseas will need to show a negative COVID-19 test before boarding a flight, but they are exempted from vaccination requirements, the White House said.

Even though there are vaccines available in the U.S. to children as young as 12, administration officials said they are sensitive to the global variability regarding access to vaccination for older children who are otherwise eligible to be vaccinated.

Similarly, the White House said people who are traveling on non-tourist visas from countries that have vaccinated less than 10 percent of their population are also exempt from the vaccine requirement. There are more than 50 countries that meet that threshold, including much of Africa, according to the World Health Organization.

“They need to have a specific, compelling reason. So, tourist visas will not qualify for that,” a senior administration official said. “If they qualify, they need to show proof of a negative test taken within 24 hours prior to departure.

Other exemptions include those with certain medical conditions, clinical trial participants and those traveling on short notice for emergency or humanitarian reasons, the official said.

==========================================

US Administration to make at-home COVID-19 tests more available

 

The Biden administration announced on Monday its plan to make rapid, at-home COVID-19 tests cheaper and more available through an accelerated Food and Drug Administration (FDA) authorization process.

The National Institutes of Health (NIH) plans to commit $70 million from the American Rescue Plan to boost the number of over-the-counter at-home COVID-19 tests on the market. I’m

Under this strategy, the Department of Health and Human Services (HHS) plans to prioritize FDA authorization applications for COVID-19 tests from companies that “have the potential for manufacturing at significant scale.”

Experts from the FDA, NIH, HHS and the Centers for Disease Control and Prevention aim to analyze and conduct studies on these tests and cooperate with companies to collect the necessary data for an FDA emergency authorization application.

Significance: Jeffrey Shuran, the director of the FDA’s Center for Devices and Radiological Health, said the streamlined policies will help attract more companies to the U.S.

“The most important step recently has been the money that the government has pumped into and continues to put into testing,” he said. “I think … the actions today are complementary to that and can expedite the assessment of candidates for over-the-counter tests.”

The need for testing is expected to jump once the administration’s vaccinate-or-test rule goes into effect for businesses with at least 100 employees.

Read more here.

The post Nicaraguans Seek Vaccines in Honduras, Moderna Safe for Kids, New US Travel Rules, More appeared first on The St Kitts Nevis Observer.